Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
168.54B
Market cap168.54B
Price-Earnings ratio
38.68
Price-Earnings ratio38.68
Dividend yield
5.89%
Dividend yield5.89%
Average volume
30.86M
Average volume30.86M
High today
$29.74
High today$29.74
Low today
$29.41
Low today$29.41
Open price
$29.74
Open price$29.74
Volume
28.48M
Volume28.48M
52 Week high
$29.88
52 Week high$29.88
52 Week low
$23.62
52 Week low$23.62

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $29.52. The company's market cap stands at 168.54B, with a P/E ratio of 38.68 and a dividend yield of 5.89%.

During the trading session on 2026-10-16, Pfizer(PFE) shares reached a daily high of $29.74 and a low of $29.41. At a current price of $29.52, the stock is +0.4% higher than the low and still -0.7% under the high.

Trading activity shows a volume of 28.48M, compared to an average daily volume of 30.86M.

The stock's 52-week range extends from a low of $23.62 to a high of $29.88.

The stock's 52-week range extends from a low of $23.62 to a high of $29.88.

PFE News

The Motley Fool 2h
Pfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe?

Last week, drugmaker Pfizer (PFE +0.36%) declared a $0.43 fourth-quarter dividend, its 352nd consecutive quarterly dividend. The forward annual dividend, theref...

Pfizer Just Declared Its 352nd Straight Quarterly Dividend. Is the 6% Yield Safe?
24/7 Wall St. 3h
Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know

Investing Bristol Myers Squibb’s 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know Bristol Myers Squibb has raised its dividend for 17 straight y...

Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know
24/7 Wall St. 4h
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady

Investing Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady Vaccine stocks are cracking under intense selling pressur...

Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady

Analyst ratings

59%

of 29 ratings
Buy
31%
Hold
58.6%
Sell
10.3%

More PFE News

Simply Wall St 9h
Pfizer Brings Fresh Phase 3 Vaccine Data To IDWeek 2026

Pfizer (NYSE:PFE) used IDWeek 2026 to present new Phase 3 results for its Lyme disease vaccine candidate. The company also reported Phase 3 data for its next g...

Pfizer Brings Fresh Phase 3 Vaccine Data To IDWeek 2026
24/7 Wall St. 1d
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher

Investing Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher Healthcare is drawing fresh buying as money moves away from the m...

Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Benzinga 1d
Pfizer Stock Hits 52-Week High: What's Going On?

Pfizer Inc (NYSE:PFE) shares are climbing Thursday to a new 52-week high as drugmakers rally broadly. The move comes a week after the FDA approved a Tukysa regi...

Pfizer Stock Hits 52-Week High: What's Going On?
The Motley Fool 1d
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

As the healthcare sector evolves, investors often choose between growth-oriented leaders and established dividend payers. Deciding between AbbVie (ABBV +2.67%)...

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Benzinga 1d
Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’

On CNBC’s “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked U.S. 10 Year Trea...

Pfizer, Thermo Fisher Scientific And More: CNBC’s ‘Final Trades’
Zacks 2d
Pfizer Gains As Market Dips: What You Should Know

Pfizer (PFE Quick QuotePFE - Free Report) closed the most recent trading day at $29.21, moving +2.96% from the previous trading session. The stock exceede...

Pfizer Gains As Market Dips: What You Should Know
TipRanks 2d
Pfizer’s Next‑Gen Pneumococcal Shot Enters Key Phase 3 Test, Extending Vaccine Growth Potential

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched a Phase 3 trial called “A PHASE 3, RANDOMIZED, DOUBLE-BLIN...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.